Defender Capital opposes STAAR Surgical sale to Alcon ahead of vote

Go back to Defender Capital opposes STAAR Surgical sale to Alcon ahead of vote

Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.

December 17, 2025 4:53 PM EST

Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised Deal

CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement reiterating its intention to vote AGAINST the... More